Circling Around On Cerecor - Cerecor Inc. (NASDAQ:CERC ... Mar 23, 2020 · Oppenheimer reiterated its Buy rating and $11 price target on Cerecor on March 12th. Maxim Group downgraded the name from Buy to Hold a day later. That is the only analyst activity on CERC … NASDAQ:CERC | Analyst Ratings Maxim Group analyst Jason McCarthy maintained a Buy rating on Cerecor (CERC – Research Report) yesterday and set a price target of $10.00. The company’s shares closed last Monday at $2.99, close to its 52-week low of $2.71. CERC - Cerecor Stock Price - Barchart.com
Cerecor Inc (NASDAQ:CERC) Director Acquires $115,862.05 in ...
Cerecor Inc. Just Released Its Yearly Earnings: Here's ... Mar 13, 2020 · Cerecor Inc. (NASDAQ:CERC) missed earnings with its latest full-year results, disappointing overly-optimistic analysts. It was not a great statutory result, with … CERECOR INC. : CERC Stock Price | MarketScreener Cerecor, Inc. is a biopharmaceutical company. The Company is focused on development and commercialization of treatments for pediatric and orphan diseases. Cerecor Inc., CERC Quick Chart - (NAS) CERC, Cerecor Inc ... Headlines for Cerecor Inc. (NAS:CERC) News for Cerecor Inc. Friday, January 10, 2020. 08:52 AM ET. Cerecor started at outperform with $11 stock price target at Oppenheimer MarketWatch. Wednesday, August 21, 2019. 07:42 AM ET. Cerecor stock soars 17% premarket after FDA grants fast-track designation to treatment for rare disorder MarketWatch.
CERC stock reached all-time highs on February with a price of $7.65. Cerecor stock price target How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts.
Cerecor (NASDAQ:CERC) Stock Price Up 23.4% | newsfilter.io Dec 24, 2019 · CERC has been the topic of several recent analyst reports. Maxim Group reiterated a “buy” rating and issued a $10.00 target price on shares of Cerecor in a report on Friday, November 15th. HC Wainwright restated a “buy” rating and set a $12.00 price target (up from $11.00) on shares of Cerecor in a report on Monday, December 2nd.
In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on Cerecor (CERC), with a price target of $11.00.[] Mar. 12, 2020 at 6:32 a.m. ET on SmarterAnalyst
Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc acquired 36,000 shares of the business’s stock in a transaction dated Friday, March 27th. The stock was purchased at an average price of $2.43 per share, with a total value of $87,480.00. Reliq Health Technologies Stock Forecast: down to 0.210 ... Wall Street Stock Market & Finance report, prediction for the future: You'll find the Reliq Health Technologies share forecasts, stock quote and buy / sell signals below. According to present data Reliq Health Technologies's RQHTF shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Cerecor stock: buy or sell? - CERC CERC stock reached all-time highs on February with a price of $7.65. Cerecor stock price target How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. Cerecor Inc (NASDAQ:CERC) Director Acquires $115,862.05 in ...
Get the latest Zacks research report on CERC — FREE. 10 ETFs With Most Upside To Analyst Targets Top 25 Broker Analyst Picks of the S&P 500. For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the ETF as far as deciding whether to continue to hold the stock.
Nov 08, 2019 · Their average twelve-month price target is $9.6667, suggesting that the stock has a possible upside of 198.35%. The high price target for CERC is $11.00 and the low price target for CERC is $8.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy.". CERC Stock Price, Forecast & News (Cerecor) | MarketBeat